A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
The work and pensions secretary is said to be thinking of throwing his hat in the ring for leadership of the Tory party.
Prior to the EU referendum Boris Johnson spoke to ITV News National Editor, Allegra Stratton, on what a post-Brexit UK would look like.
The woman, called Karen, was in tears as she spoke about the xenophobic attacks she has suffered since the EU referendum.